1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Chronic Pain Management Research Program is sponsored by Congressionally Directed Medical Research Programs (CDMRP), Department of Defense (DoD). This program supports innovative, high-impact research to prevent the development and improve the management of chronic pain, with a focus on issues related to military populations.
Research priorities include the development of non-opioid therapies, understanding the chronification of pain, and effectiveness studies of novel techniques, which can encompass studies on central sensitization and endogenous inhibition.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Open to academic, private, and government organizations. Eligibility typically includes US and international organizations. Refer to specific program announcements for full details. Confirm the full requirements in the official notice before applying.
Chronic Pain Management Research Program is funded by Congressionally Directed Medical Research Programs (CDMRP), Department of Defense (DoD). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read article